Clinical Trial Update: Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating chidamide, decitabine, and immune checkpoint inhibitors in relapsed/refractory non-Hodgkin lymphoma and advanced solid tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Solid Tumors

Drugs mentioned

• Chidamide (chidamide)
• Decitabine (Decitabine)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Relapsed/Refractory Non-Hodgkin Lymphoma, Advanced Solid Tumors | Phase 1, Phase 2 | Status: UNKNOWN